Lipella Pharmaceuticals (LIPO) Q2 2024 Earnings

9MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2024
-0.26
-0.17
-0.09
0

Details

Expected EPS
-0.16
Actual EPS
-0.16
Surprise EPS
0
Surprise Percent
+0%

Description

Lipella Pharmaceuticals (LIPO) has reported earnings of -0.16 per share for Q2 2024.

0 Comments

Share your thoughts